Covered recipient · General Payments record
GREGORY S WEATHERFORD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$539.21
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $349.72 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $44.78 | 3 |
| Novo Nordisk AS | $41.50 | 2 |
| UCB, Inc. | $35.78 | 1 |
| Neurocrine BioSciences, Inc. | $30.02 | 1 |
| IMPULSE DYNAMICS (USA) INC. | $29.82 | 1 |
| Ardelyx, Inc. | $27.53 | 1 |
| E.R. Squibb & Sons, L.L.C. | $26.63 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.11 | 1 |
| Exact Sciences Corporation | $25.15 | 1 |
| DEXCOM, INC. | $23.29 | 1 |
| Otsuka America Pharmaceutical, Inc. | $22.22 | 1 |
| GlaxoSmithKline, LLC. | $16.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $13.95 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411670 | CMS |
| Amgen Inc. | $15.93 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411672 | CMS |
| Amgen Inc. | $14.90 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117411674 | CMS |
| Ardelyx, Inc. | $27.53 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146713679 | CMS |
| Dexcom, Inc. | $23.29 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153302409 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.63 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101512789 | CMS |
| Exact Sciences Corporation | $25.15 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114946325 | CMS |
| GlaxoSmithKline, LLC. | $16.89 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116560568 | CMS |
| Impulse Dynamics (USA) Inc. | $29.82 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100409568 | CMS |
| Neurocrine Biosciences, Inc. | $30.02 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150825908 | CMS |
| Novartis Pharmaceuticals Corporation | $26.11 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087436262 | CMS |
| Novo Nordisk Inc | $22.12 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096600047 | CMS |
| Novo Nordisk Inc | $19.38 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097274224 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.22 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119002947 | CMS |
| UCB, Inc. | $35.78 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143113919 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.